相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications
Nathaniel J. Henning et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
Image-Based Annotation of Chemogenomic Libraries for Phenotypic Screening
Amelie Tjaden et al.
MOLECULES (2022)
Small molecule targeting of chromatin writers in cancer
Andrew R. Conery et al.
NATURE CHEMICAL BIOLOGY (2022)
Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic
Zhenyi Hu et al.
CHEMBIOCHEM (2022)
Targeting epigenetic modulators using PROTAC degraders: Current status and future perspective
Thomas Webb et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
BET bromodomain inhibitors
Martin P. Schwalm et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2022)
The Ascension of Targeted Covalent Inhibitors
Juswinder Singh
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Fluorescent and Bioluminescent Calcium Indicators with Tuneable Colors and Affinities
Nicole Mertes et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
Dongxu Li et al.
ONCOGENE (2022)
A Toolbox for the Generation of Chemical Probes for Baculovirus IAP Repeat Containing Proteins
Martin P. Schwalm et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Target 2035-update on the quest for a probe for every protein
Susanne Mueller et al.
RSC MEDICINAL CHEMISTRY (2022)
Selective targeting of non-centrosomal AURKA functions through use of a targeted protein degradation tool
Richard Wang et al.
COMMUNICATIONS BIOLOGY (2021)
PROTAC-DB: an online database of PROTACs
Gaoqi Weng et al.
NUCLEIC ACIDS RESEARCH (2021)
Solution Conformations Shed Light on PROTAC Cell Permeability
Yoseph Atilaw et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Development of BromoTag: A Bump-and-Hole-PROTAC System to Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins
Adam G. Bond et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of a Highly Potent and Selective Degrader Targeting Hematopoietic Prostaglandin D Synthase via In Silico Design
Hidetomo Yokoo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Amide-to-Ester Substitution as a Strategy for Optimizing PROTAC Permeability and Cellular Activity
Victoria G. Klein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models
Xufen Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
The Promise and Peril of Chemical Probe Negative Controls
Jinyoung Lee et al.
ACS CHEMICAL BIOLOGY (2021)
Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders
Anja Doelle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras
Xiaoyu Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation
Carlotta Cecchini et al.
FRONTIERS IN CHEMISTRY (2021)
A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination
Ellen F. Vieux et al.
SLAS DISCOVERY (2021)
Prediction of Chameleonic Efficiency
Laurent David et al.
CHEMMEDCHEM (2021)
Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP
Mengzhu Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Trends in kinase drug discovery: targets, indications and inhibitor design
Misty M. Attwood et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
The PROTACtable genome
Melanie Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Engineering Single Pan-Specific Ubiquibodies for Targeted Degradation of All Forms of Endogenous ERK Protein Kinase
Erin A. Stephens et al.
ACS SYNTHETIC BIOLOGY (2021)
Chemo-proteomics exploration of HDAC degradability by small molecule degraders
Yuan Xiong et al.
CELL CHEMICAL BIOLOGY (2021)
Targeted protein degradation: A promise for undruggable proteins
Kusal T. G. Samarasinghe et al.
CELL CHEMICAL BIOLOGY (2021)
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2
Benedict-Tilman Berger et al.
CELL CHEMICAL BIOLOGY (2021)
Genomics-driven drug discovery based on disease-susceptibility genes
Kyuto Sonehara et al.
INFLAMMATION AND REGENERATION (2021)
Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function
Mai Luo et al.
CELL CHEMICAL BIOLOGY (2021)
Structure-Based Design of a Macrocyclic PROTAC
Andrea Testa et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Critical Assessment of Targeted Protein Degradation as a Research Tool and Pharmacological Modality
Milka Kostic et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs
Ronen Gabizon et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Targeted Degradation of Oncogenic KRASG12C by VHL-Recruiting PROTACs
Michael J. Bond et al.
ACS CENTRAL SCIENCE (2020)
Understanding and Improving the Membrane Permeability of VH032-Based PROTACs
Victoria G. Klein et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes
Daniel Zaidman et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
Bikash Adhikari et al.
NATURE CHEMICAL BIOLOGY (2020)
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
Wen-Hao Guo et al.
NATURE COMMUNICATIONS (2020)
Bardoxolone conjugation enables targeted protein degradation of BRD4
Bingqi Tong et al.
SCIENTIFIC REPORTS (2020)
Advances in Genomics for Drug Development
Roberto Spreafico et al.
GENES (2020)
Pan-SMARCA/PB1 Bromodomain Inhibitors and Their Role in Regulating Adipogenesis
Marek Wanior et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
Alina Mares et al.
COMMUNICATIONS BIOLOGY (2020)
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications
Carl C. Ward et al.
ACS CHEMICAL BIOLOGY (2019)
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Stefanie Lindner et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges
Scott D. Edmondson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
George M. Burslem et al.
CANCER RESEARCH (2019)
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
William Farnaby et al.
NATURE CHEMICAL BIOLOGY (2019)
Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16
Xiaoyu Zhang et al.
NATURE CHEMICAL BIOLOGY (2019)
PROTACs- a game-changing technology
Markella Konstantinidou et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders
Shang Su et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Enzymatic Logic of Ubiquitin Chain Assembly
Kirandeep K. Deol et al.
FRONTIERS IN PHYSIOLOGY (2019)
Public resources for chemical probes: the journey so far and the road ahead
Albert A Antolin et al.
Future Medicinal Chemistry (2019)
Linker length affects photostability of protein-targeted sensor of cellular microviscosity
Marketa Kubankova et al.
METHODS AND APPLICATIONS IN FLUORESCENCE (2019)
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel-Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
Vittoria Zoppi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Blake E. Smith et al.
NATURE COMMUNICATIONS (2019)
PROTAC-Mediated Degradation of Bruton's Tyrosine Kinase Is Inhibited by Covalent Binding
Christopher P. Tinworth et al.
ACS CHEMICAL BIOLOGY (2019)
SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate
Michael J. Roy et al.
ACS CHEMICAL BIOLOGY (2019)
Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML
Matthias Brand et al.
CELL CHEMICAL BIOLOGY (2019)
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
Calla M. Olson et al.
NATURE CHEMICAL BIOLOGY (2018)
The Cysteinome of Protein Kinases as a Target in Drug Development
Apirat Chaikuad et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Genomic insights into the causes of type 2 diabetes
Claudia Langenberg et al.
LANCET (2018)
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma
Xiaohui Zhang et al.
LEUKEMIA (2018)
Plasticity in binding confers selectivity in ligand-induced protein degradation
Radoslaw P. Nowak et al.
NATURE CHEMICAL BIOLOGY (2018)
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
Lara N. Gechijian et al.
NATURE CHEMICAL BIOLOGY (2018)
Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma
Liang Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8
John M. Hatcher et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Modulating PCAF/GCN5 Immune Cell Function through a PROTAC Approach
Zuni I. Bassi et al.
ACS CHEMICAL BIOLOGY (2018)
Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action
Kristin M. Riching et al.
ACS CHEMICAL BIOLOGY (2018)
CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide
Marie K. Schwinn et al.
ACS CHEMICAL BIOLOGY (2018)
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
Hai-Tsang Huang et al.
CELL CHEMICAL BIOLOGY (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
Chemical probes targeting epigenetic proteins: Applications beyond oncology
Suzanne Ackloo et al.
EPIGENETICS (2017)
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
Georg E. Winter et al.
MOLECULAR CELL (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
WD40 repeat domain proteins: a novel target class?
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Assessing histone demethylase inhibitors in cells: lessons learned
Stephanie B. Hatch et al.
EPIGENETICS & CHROMATIN (2017)
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology
Julian Blagg et al.
CANCER CELL (2017)
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
David Remillard et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway
Ian Collins et al.
BIOCHEMICAL JOURNAL (2017)
A chemical probe toolbox for dissecting the cancer epigenome
Jake Shortt et al.
NATURE REVIEWS CANCER (2017)
Small-Molecule PROTACS: New Approaches to Protein Degradation
Momar Toure et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1)
Matthaeus Getlik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket
Michael Forster et al.
CELL CHEMICAL BIOLOGY (2016)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNFMutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi et al.
CANCER RESEARCH (2015)
Mapping Proteome-Wide Targets of Environmental Chemicals Using Reactivity-Based Chemoproteomic Platforms
Daniel Medina-Cleghorn et al.
CHEMISTRY & BIOLOGY (2015)
Open access chemical probes for epigenetic targets
Peter J. Brown et al.
FUTURE MEDICINAL CHEMISTRY (2015)
The ins and outs of selective kinase inhibitor development
Susanne Mueller et al.
NATURE CHEMICAL BIOLOGY (2015)
The promise and peril of chemical probes
Cheryl H. Arrowsmith et al.
NATURE CHEMICAL BIOLOGY (2015)
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance
Oleg Fedorov et al.
SCIENCE ADVANCES (2015)
Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable
Daniel S. Nielsen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination
Meredith B. Metzger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Pietro Ciceri et al.
NATURE CHEMICAL BIOLOGY (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids
Dawn M. Wenzel et al.
NATURE (2011)
Probing the Probes: Fitness Factors For Small Molecule Tools
Paul Workman et al.
CHEMISTRY & BIOLOGY (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Detection of sequential polyubiquitylation on a millisecond timescale
Nathan W. Pierce et al.
NATURE (2009)
A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate
Wei Li et al.
NATURE (2007)
Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179
Rehan Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)